Salt la conținut
Global sound
pharmaphorum Podcast

pharmaphorum Podcast

ESMO26: Lowering toxicity, extending lives, with Syncromune

· 11 min

Note de episod

As the European Society for Medical Oncology 2026 Congress commences in Madrid, pharmaphorum invited Syncromune Executive Chairman Dr Chuck Link onto the podcast for a conversation on the updated long-term overall survival data from its Phase 1 trial of SYNC-T Therapy SV-102 in patients with metastatic prostate cancer.
Dr Link discusses SYNC-T, their investigational in situ personalised immunotherapy, as well as metastatic castration-resistant (or mCRPC) and metastatic hormone-sensitive (or mHSPC) disease, and the possible outcomes for patients going forward.
Listen to the conversation and keep up on ESMO26 updates here.

Site: pharmaphorum.podbean.com

Live, ultima oră: 7.623 melodii pe 3.114 posturi din 122 țări

Descoperă lumea prin radio

Mai multe moduri de a descoperi (7)

Ai auzit ceva frumos? Salvează-l sau deschide-l direct în Spotify.

★ Artist of the week The fastest riser on the radio this week
Your song here? From € 9 per week →
1045 The VaultContinuă să asculți